Stanford Investment Group’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Stanford Investment Group’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-24	Closed	–	–	347
2016 Q4	$0	Hold	24	–	–	﹤0.01%	422
2016 Q3	$0	Hold	24	–	–	﹤0.01%	419
2016 Q2	$0	Hold	24	–	–	﹤0.01%	370
2016 Q1	$0	Hold	24	–	–	﹤0.01%	372
2015 Q4	$0	Buy	+24	New	+$24	﹤0.01%	352
2015 Q2	–	Sell	-24	Closed	–	–	373
2015 Q1	$0	Hold	24	–	–	﹤0.01%	361
2014 Q4	$0	Buy	+24	New	+$26	﹤0.01%	346

Other funds holding BTX.WS

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Stanford Investment Group's BTX.WS Position: Q1 2017 in Review

Stanford Investment Group sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q1 2017, closing a stake of 24 shares.

Stanford Investment Group first reported a position in BTX.WS in Q4 2014 and held it in 7 quarters. The position peaked at $0 in Q4 2016. 37 funds tracked by Wall St. Rank hold BTX.WS as of Q1 2017.

Stanford Investment Group reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q1 2017 after selling out during the quarter.
Stanford Investment Group sold 24 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q1 2017.
Stanford Investment Group first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 7 quarters.
Stanford Investment Group's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $0 in Q4 2016.
37 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.